| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 22 | |
| #2 | United States | 6 | |
| #3 | WIPO (World Intellectual Property Organization) | 6 | |
| #4 | EPO (European Patent Office) | 5 | |
| #5 | Canada | 4 | |
| #6 | Republic of Korea | 3 | |
| #7 | Australia | 2 | |
| #8 | Mexico | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Steroids | |
| #6 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Pardoe Ian Stuart | 22 |
| #2 | Hartley Christopher | 9 |
| #3 | Hartley Christopher Edward | 6 |
| #4 | Burden John | 1 |
| #5 | Hartley Christopher Edward Henderson | 1 |
| #6 | Dargan Derrick James | 1 |
| #7 | Patel Arvind | 1 |
| #8 | Hartley Christopher E | 1 |
| #9 | Subak-Sharpe John Herbert | 1 |
| #10 | Pardoe Ian | 1 |
| Publication | Filing date | Title |
|---|---|---|
| GB201008793D0 | vaccines | |
| GB201008795D0 | Vaccines | |
| GB201008788D0 | Vaccines | |
| GB201008786D0 | Vaccines | |
| GB0909146D0 | Vaccines | |
| GB0909145D0 | Vaccines | |
| GB0909144D0 | Vaccines | |
| GB0909147D0 | Vaccines | |
| GB0907935D0 | Vaccines | |
| GB0823425D0 | Vectors | |
| GB0806344D0 | Vaccine adjuvant | |
| WO2009103932A1 | Use of a cardiac glycoside and/or a diuretic for the treatment of neuropathic pain | |
| GB0802365D0 | Disease control | |
| GB0616451D0 | Dna viral infections | |
| GB0616450D0 | Pharmaceutical composition for the treatment of neuropathic pain | |
| GB0519554D0 | Modifying leukocyte function | |
| GB0517842D0 | Neuropathic pain | |
| GB0517840D0 | Topical anti viral formulations | |
| GB0517838D0 | Transdermal active principle delivery means | |
| GB0517835D0 | DNA viral infections |